Please assess the completion status of the following clinical trial:

Trial Title: Gelatin in ICU and Sepsis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients ≥ 18 years of age~* Women of child bearing potential must test negative on standard pregnancy test (urine or serum)~* Patients with body weight ≤ 140 kg~* Patients diagnosed severe sepsis / septic shock at admission on Intensive Care Unit who can be enrolled within 90 min after admission OR patients diagnosed severe sepsis / septic shock during Intensive Care Unit stay who can be enrolled within 90 min after diagnosis~* Patients where antibiotic therapy has already been started (prior to randomization)~* Patient who are fluid responsive. Fluid responsiveness is defined as increase of \> 10% in mean arterial pressure (MAP) after passive leg raising (PLR)~* Signed informed consent by patient, legal representative or authorized person or deferred consent~Exclusion Criteria:~* Administration of HES, dextrane solutions or \> 500 ml of Gelatin solutions within the 24 h prior to randomization~* Death expected within the next 48 h (moribund patients as defined by ASA ≥ class V)~* Patients for whom the need of pressure infusions are expected~* Patients with confirmed acute SARS-CoV-2 (COVID-19) infection (as available from routine medical records/ patient chart)~* Requirement for renal support (either continuous or discontinuous techniques, including intermittent haemodialysis, haemofiltration and haemodiafiltration)~* Patients receiving therapeutic heparin medication due to chronic coagulation disease / anticoagulation medication (i.e. partial thromboplastin time \> 60 sec)~* Acutely burned patients~* Contraindications according to summary of product characteristics of investigational test and reference product~* Simultaneous participation in another interventional clinical trial (drugs or medical devices studies)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Gelatine (Type: EXPERIMENTAL): Balanced gelatine solution
- Electrolyte (Type: ACTIVE_COMPARATOR): Balanced electrolyte solution

Based on this trial design, predict the completion outcome and termination type (if applicable).